22个国家缺血性和出血性卒中危险因素病例对照研究Risk Factors for Ischemic and Intracerebral HemorrhagicStroke in 22 Countries（INTERSTROKE）study骨保护素osteoprotegerin（OPG）国际动脉粥样硬化学会International Atheroscle...22个国家缺血性和出血性卒中危险因素病例对照研究Risk Factors for Ischemic and Intracerebral HemorrhagicStroke in 22 Countries（INTERSTROKE）study骨保护素osteoprotegerin（OPG）国际动脉粥样硬化学会International Atherosclerosis Society（IAS）国际糖尿病联盟International Diabetes Federation（IDF）国际头痛疾病分类第2版International Classification of Headache Disorders展开更多
阿哌沙班减少心房颤动相关性卒中和其他栓塞事件研究Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation(ARISTOTLE)阿哌沙班与阿司匹林预防维生素K拮抗剂无效或不适用的心房颤动患者脑卒中比...阿哌沙班减少心房颤动相关性卒中和其他栓塞事件研究Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation(ARISTOTLE)阿哌沙班与阿司匹林预防维生素K拮抗剂无效或不适用的心房颤动患者脑卒中比较研究Apixaban versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment(AVERROES)studyγ-氨基丁酸γ-aminobutyric acid(GABA)半高全宽full width half maximum(FWHM)展开更多
文摘22个国家缺血性和出血性卒中危险因素病例对照研究Risk Factors for Ischemic and Intracerebral HemorrhagicStroke in 22 Countries（INTERSTROKE）study骨保护素osteoprotegerin（OPG）国际动脉粥样硬化学会International Atherosclerosis Society（IAS）国际糖尿病联盟International Diabetes Federation（IDF）国际头痛疾病分类第2版International Classification of Headache Disorders
文摘阿哌沙班减少心房颤动相关性卒中和其他栓塞事件研究Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation(ARISTOTLE)阿哌沙班与阿司匹林预防维生素K拮抗剂无效或不适用的心房颤动患者脑卒中比较研究Apixaban versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment(AVERROES)studyγ-氨基丁酸γ-aminobutyric acid(GABA)半高全宽full width half maximum(FWHM)
